Peptides from pseudomonas syringae possessing broad-spectrum antibiotic activity
US5576298A · kind A · utility
16Cited by
0References
28Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 15, 1994 |
| Grant date | Nov 19, 1996 |
| Priority date | — |
| Expiry date | Sep 15, 2014 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S435/874
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Peptide antimycotics, termed pseudomycins, display broad spectrum antibiotic activity, and in particular are highly effective, non-toxic antibiotics against fungal pathogens of human and animal disease. The peptide antimycotics (pseudomycins) may be used in the treatment of the fungal pathogen Candida albicans. Also disclosed is a method of purification and isolation, including characterization, of the pseudomycins.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.